LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.06 | 17.25 | 1768 | 5242 | 0.3372 | 0.7530 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.06 | 17.25 | 2223 | 5242 | 0.4240 | 0.8024 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.06 | 17.25 | 2249 | 5242 | 0.4290 | 0.8049 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.03 | 17.25 | 1783 | 5367 | 0.3322 | 0.7508 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.03 | 17.25 | 1820 | 5367 | 0.3391 | 0.7552 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.03 | 17.25 | 2246 | 5367 | 0.4185 | 0.8003 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.03 | 17.25 | 2273 | 5367 | 0.4235 | 0.8029 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.00 | 17.25 | 1844 | 5546 | 0.3324 | 0.7523 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.00 | 17.25 | 1872 | 5546 | 0.3375 | 0.7555 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.00 | 17.25 | 2294 | 5546 | 0.4136 | 0.7988 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.00 | 17.25 | 2326 | 5546 | 0.4193 | 0.8018 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.97 | 17.25 | 1900 | 5618 | 0.3382 | 0.7564 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.97 | 17.25 | 1935 | 5618 | 0.3444 | 0.7602 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.97 | 17.25 | 2398 | 5618 | 0.4268 | 0.8061 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.97 | 17.25 | 2428 | 5618 | 0.4321 | 0.8087 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.94 | 17.25 | 1929 | 5681 | 0.3395 | 0.7577 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.94 | 17.25 | 1962 | 5681 | 0.3453 | 0.7612 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.94 | 17.25 | 2473 | 5681 | 0.4353 | 0.8107 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.94 | 17.25 | 2506 | 5681 | 0.4411 | 0.8135 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.91 | 17.25 | 1941 | 5730 | 0.3387 | 0.7575 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.91 | 17.25 | 2018 | 5730 | 0.3522 | 0.7657 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.91 | 17.25 | 2492 | 5730 | 0.4349 | 0.8107 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.91 | 17.25 | 2528 | 5730 | 0.4411 | 0.8138 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.88 | 17.25 | 2030 | 5826 | 0.3484 | 0.7641 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.88 | 17.25 | 2073 | 5826 | 0.3558 | 0.7685 | MN20160310_N02 | F03 |